Actively Recruiting

Age: 1Month - 16Years
All Genders
ID04923828

Chinese PICU Collaborative Network on Pathogens and Drug Resistance of Severe Infections

Led by Children's Hospital of Fudan University · Updated on 2026-02-17

2000

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

C

Children's Hospital of Fudan University

Lead Sponsor

S

Shanghai Children's Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying severe infections in Pediatric Intensive Care Units (PICUs) across major cities in China. The goal is to create a high-quality, standardized clinical database of PICU inpatients to understand the incidence, death rates, pathogen types, and treatments used for community-acquired and hospital-acquired infections in these patients. This observational study includes all patients admitted to PICUs from January 1, 2016, to December 31, 2025, with follow-up until death or withdrawal from the PICU. The study collects a wide range of clinical information through a standardized database, including patient general information, infection details, treatments administered in the PICU, catheter use, and short-term prognosis. Data is gathered from all eligible PICU patients during the study period to monitor infection patterns and drug resistance trends. Participants are observed throughout their PICU stay, with clinical data recorded on infection characteristics and treatment outcomes. Researchers will analyze the types of pathogens causing infections and their resistance to drugs as the primary outcome. The study runs until the end of 2025, providing comprehensive data to improve understanding and management of severe infections in pediatric critical care.

CONDITIONS

Brief Title

Chinese PICU Collaborative Network on Pathogens and Drug Resistance of Severe Infections

Who Can Participate

Age: 1Month - 16Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • PICU patients with severe infection
Not Eligible

You will not qualify if you...

  • Non-infected patient

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Monitoring

Duration - From PICU admission until death or PICU withdrawal, up to 10 years

Participants who are admitted to the PICU with severe infection are observed and their clinical data are collected throughout their stay.

Data collected continuously during PICU stay

Trial Site Locations

Total: 1 location

1

Children's Hospital of Fudan University

Shanghai, Shanghai Municipality, China

Actively Recruiting

Loading map...

Research Team

G

Guoping Lu, Doctor

J

Jing Liu, Master

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Clinical Study of Individualized Vancomycin Dosing Based on ...

Severe Infection

Actively Recruiting

1 location

Observatory of Pediatric Severe Community Bacterial Infectio...

Hospitalized Children

Actively Recruiting

1 location

Multicenter Observational Study of Infectious Complications ...

Lymphoma Neoplasms

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here